Special Service Offer for
miRNA Discoveries
Time-limited offer for low-input samples
Save up to 30% on your miRNA-Seq Service
Small but powerful!
Mastering high-sensitivity biomarker discoveries from low-input samples with Lexogen's miRNA-Seq Service!
≥ 24 samples
Ideal for low-input or degraded samples
Compatible with blood, biofluids, FFPE, EVs etc.
For new customers only
Time-limited offer until end of June 2026
Is your project a fit? Fill out the form to receive your offer!
Terms & Conditions
-
This promotion is run by Lexogen GmbH (hereafter referred to as “Lexogen”) and shall exclusively be governed by the Terms and Conditions below and by “General Terms and Conditions of Sales of Lexogen GmbH” in the version respectively in effect at the time of the conclusion of each contract. The current version of the General Terms and Conditions of Sales of Lexogen GmbH is available at www.lexogen.com/terms-and-conditions or can be requested free of charge at info@lexogen.com.
-
This special offer is valid until June 30th, 2026 (Purchase Order income). Samples need to be delivered to Lexogen’s NGS Service facility by July 31st, 2026.
-
Only Service requests are eligible for the special offer that are submitted within the promotion period. Existing service projects and re-submissions of previous requests are excluded.
-
The promotion covers the preparation of small RNA-Seq libraries using Lexogen's advanced miRNA-Seq library generation technology and sequencing (on average 8 M reads/ sample) of 24 samples or more. RNA extraction, spike-in controls (SIRVs), and data analysis are not included but are available at extra costs. Minimal RNA input is 1 ng of total RNA per sample.
-
Requests can be directed to Lexogen by using the form above or by e-mailing to services@lexogen.com.
-
This promotion cannot be combined with other offerings.
-
Terms and conditions are subject to change at any time without notice. Other restrictions may apply.
-
These General Terms and Conditions of Sales of Lexogen GmbH shall be subject to and construed in accordance with Austrian law.
“QuantSeq from Lexogen is everything we dreamed of and more. All we had to do was to send our samples off for analysis, and wait shortly to hear back from Lexogen. As an added bonus everyone at Lexogen was extremely knowledgeable, kind, and more than eager to answer any questions we had. We highly recommend using QuantSeq service of Lexogen.”
“Throughout my career, leading genomic projects and departments, I have always been a fan of Lexogen chemistry. When I finally decided to co-found a genomics company, I was delighted to hear that Lexogen had a services arm, and signed up immediately. We work with extremely challenging samples, from biobanked FFPEs to micro-organ samples. At every step Lexogen has worked closely with us, even helping to optimise our protocols, to ensure the best possible results.”
About Lexogen
Lexogen is a biotech company focusing on RNA and complete transcriptome studies using next generation sequencing technologies.
We have been at the forefront of RNA research since 2007, and our technologies and products are being used by thousands of scientists all over the world. “Lexo” in Greek means “word”, and Lexogen stands for the word of genes, which is the transcriptome. We strive to be the pioneers in this fascinating field of RNA science, and together with the fastest-growing technology of the past years, the next generation sequencing (NGS), we are sure that we can make a big contribution to the world.
Email
info@lexogen.com
Telephone:
US +1-603-431-4300
Rest of the world +43 (0) 1 345 1212
Lexogen ISO certifications
We proudly hold both ISO 9001 and ISO 13485 certifications, which not only demonstrate our drive for innovation but also our unwavering devotion to delivering reliable, robust, and cutting-edge solutions to our valued customers.
